208
Views
27
CrossRef citations to date
0
Altmetric
Miscellaneous

Ropivacaine

&
Pages 325-336 | Published online: 24 Feb 2005

Bibliography

  • EKENSTAM B AF, EGNER B, PETTERSSON G: LocalAnaesthetics I. N-alkyl pyrrolidine and n-alkyl piperidine carboxylic acid amides. Acta Chem. Scand. (1957) 11 (7) :1183–1190.
  • ALBRIGHT GA: Cardiac arrest following regionalanesthesia with etidocaine or bupivacaine. Anesthesi-ology (1979) 51(0285–287.
  • VANHOUTTE F, VEREECKE J, VERBEKE N, CARMELIET E:Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br. J. Pharmacol (1991) 103 :1275–1281.
  • BADER AM, DATTA S, FLANAGAN H, COVINO BG: Comparison of bupivacaine- and ropivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth. Analg. (1989) 68(6):724–727.
  • ••Shows greater sensory to motor block differential withropivaciane.
  • TUCKER GT: Pharmacokinetics of local anaesthetics. Br. J. Anaesth. (1986) 58(7):717–731.
  • ••Excellent review of local anaesthetic pharmacokineticsunder various physiological conditions.
  • RUTTEN AJ, MATHER LE, NANCARROW C, SLOAN PA, MCLEAN CF: Cardiovascular effects and regional clearances of intravenous ropivacaine in sheep. Anesth. Analg. (1990) 70(6):577–82.
  • ARTHUR GR, FELDMAN HS, COVINO BG: Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth. Analg. (1988) 67(10:1053–1058.
  • •Demonstrates how pharmacokinetic factors vary by route of administration.
  • MCLURE JH: Ropivacaine. Br. J. Anaesth. (1996) 76:300–307.
  • •Nice review.
  • ARLOCK P: Actions of three local anaesthetics: lidocaine, bupivacaine and ropivacaine on guinea pig papillary muscle sodium channels (V„.,.,J. Pharmacol Toxicol. (1988) 63:96–104.
  • MOLLER R, COVINO BG: Cardiac electrophysiologic properties of bupivacaine and lidocaine compared with those of ropivacaine, a new amide local anesthetic. Anesthesiology (1990) 72:322–329.
  • REIZ S, HAGGMARK S, JOHANSSON G, NATH S: Cardiotoxicity of ropivacaine - a new amide local anaesthetic agent. Acta Anaesthesiol. Scand. (1989) 33:93–98.
  • NANCARROW C, RUTTEN AJ, RUNCIMAN WB et al: Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth. Analg. (1989) 69:276–283.
  • ••Provides information on CNS and cardiovascular toxicitylimits and establishes ratio of fatal doses among 3 local anaesthetics.
  • FELDMAN HS, ARTHUR GR, COVINO BG: Comparativesystemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth. Analg. (1989) 69:794–801.
  • FELDMAN HS, ARTHUR GR, PITKANEN M, HURLEY R, DOUCETTE AM, COVINO BG: Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth. Analg. (1991) 73:373–384.
  • •Discusses cardiac manifestations and resuscitation after iv. local anaesthetic overdose.
  • SANTOS AC, ARTHUR GR, WLODY D, DE ARMAS P, MORISHIMA HO, FINSTER M Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology (1995) 82:734–740.
  • •Refutes claims that pregnancy increases local anaesthetic toxicity.
  • MORISHIMA HO, PEDERSEN H, FINSTER M et al.:Bupivacaine toxicity in pregnant and nonpregnant ewes. Anesthesiology (1985) 63:134–139.
  • SCOTT DB, LEE A, FAGAN D, BOWLER GMR, BLOOMFIELD P, LUNDH R: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth. Analg. (1989) 69:563–569.
  • •CNS symptoms following ropivacaine or bupivacaine.
  • KNUDSEN K, SUURKgLA MB, BLOMBERG S, SJ VALL J, EDVARDSSON N: Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br. J. Anaesth. (1997) 78:507–514.
  • •Echocardiographic and ECG changes following iv. ropivacaine and bupivacaine.
  • EMANUELSSON BMK, PERSSON J, ALM C, HELLER A, GUSTAFSSON LL: Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology (1997) 87:1309–1317.
  • FATTORINI F, PASCARELLA MA, BENVENUTI SG et al.:Use of ropivacaine in axillary brachial plexus block. Clin. Ter. (1997) 148(10:527–530.
  • DATTA S, CAMANN W, BADER A, VANDERBURGH L: Clinical effects and maternal and fetal plasma concen-trations of epidural ropivacaine versus bupivacaine for caesarean section. Anesthesiology (1 9 9 5) 82:1346-1352.
  • ALAHUHTA S, RASANEN J, JOUPPILA P et al.: The effects of epidural ropivacaine and bupivacaine for caesarean section on uteroplacental and fetal circulation. Anesthesiology (1995) 83:23–32.
  • •Uses colour Doppler ultrasound to measure changes in foetal blood flow after large epidural doses of ropivacaine or bupivacaine.
  • BJØRNESTAD E, SMEDVIG JP, BJERKREIM T, NARVERUD G, KOLLEROS D, BERGHEIM R: Epidural ropivacaine 7.5 mg/mg for elective caesarean section: a double-blind comparison of efficacy and tolerability with bupivacaine 5 mg/ml. Acta Anaesthesiol Scand. (1999) 43:603–608.
  • IRESTEDT L, EKBLOM A, OLOFSSON C, DAHLSTR_M A-C,EMANUELSSON B-M: Pharmacokinetics and clinical effect during continuous epidural infusion with ropivacaine 2.5 mg/ml or bupivacaine 2.5 mg/ml for labour pain relief. Acta Anaesth. Scand. (1998) 42:890–896.
  • STIENSTRA R, JONKER TA, BOURDREZ P, KUIJPERS JC,VAN KLEEF JW, LUNDBERG U: Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: a double-blind comparison. Anesth. Analg. (1995) 80:285–289.
  • •Well written labour study.
  • GAISER RR, VENKATESWAREN P, CHEEK TG et al. Comparison of 0.25% ropivacaine and bupivacaine for epidural analgesia for labor and vaginal delivery. J. Clin. Anesth. (1997) 9:564–568.
  • CROSBY E, SANDLER A, FINUCANE B et al.: Comparison of epidural anaesthesia with ropivacaine 0.5% and bupivacaine 0.5% for caesarean section. Can. J. Anaesth. (1998) 45(10:1066–1071.
  • GRIFFIN RP, REYNOLDS F: Extradural anaesthesia for caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br. J. Anaesth. (1995) 74:512–516.
  • EDDLESTON JM, HOLLAND JJ, GRIFFIN RP, CORBETT A, HORSMAN EL, REYNOLDS F: A double-blind compar-ison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labour. Br. J. Anaesth. (1996) 76:66–71.
  • MUIR HA, WRITER D, DOUGLAS J, WEEKS S, GAMGLING D, MACARTHUR A: Double-blind comparison of epidural ropivacaine 0.25% and bupivacaine 0.25%, for the relief of childbirth pain. Can. J. Anaesth. (1997) 44(6)599–604.
  • MCCREA AF, JOZWIAK H, MCCLURE JH: Comparison of ropivacaine and bupivacaine in extradural analgesia for the relief of pain in labour. Br. J. Anaesth. (1995) 74:261–265.
  • OWEN MD, D'ANGELO R, GERANCHER JC et al.: 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth. Analg. (1998) 86:527–531.
  • POLLEY LS, COLUMB MO, NAUGHTON NN, WAGNER DS, VAN DE VEN CJ: Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes. Anesthesi-ology (1999) 90(4):944–950.
  • •Estimates ED50 using sequential up-down study design.
  • CAPOGNA G, CELLENO D, FUSCO P, LYONS G, COLUMB M: Relative potencies of bupivacaine and ropivacaine for analgesia in labour. Br. J. Anaesth. (1999) 82 (3):371–373.
  • REYNOLDS F: Does the left hand know what the right hand is doing? An appraisal of single enantiomer local anaesthetics. Int. j Obstet. Anaesth. (1997) 6:257–269.
  • ••Well written review.
  • MEISTER G, OWEN M, D'ANGELO R, GAVER R: Compar-ison of 0.125% ropivacaine+fentanyl 2 mg/ml and 0.125% bupivacaine+fentanyl 2 mg/ml in laboring patients. Anesthesiology (1998) 88:A5.
  • ZARIC D, NYDAHL P-A, PHILIPSON L, SAMUELSSON L, HEIERSON A, AXELSSON K: The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2%, and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers. A double-blind study. Reg. Anesth. (1996) 21(0:14–25.
  • D'ANGELO R: Is there a place for ropivacaine/levobupivacaine in obstetric anesthesia? American Society of Regional Anesthesia 24th Annual Meeting & Workshops, Regional Anesthesia and Pain Medicine, Philadelphia, Pennsylvania, USA (1999) 480–485.
  • •Discusses the cost issue between local anaesthetics.
  • BRODNER G, MERTES N, VAN AKEN H, POGATZKI E, BUERKLE H, MARCUS MA, MOLLHOFF T: Epidural analgesia with local anesthetics after abdominal surgery: Earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine. Anesth. Analg. (1999) 88:128–33.
  • ••Potential cost sparing effect of ropivacaine.
  • HUANG YF, PRYOR ME, MATHER LE, VEERING BT: Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth. Analg. (1998) 86(4):797–804.
  • BARDSLEY H, GRISTWOOD R, BAKER H, WATSON N, NIMMO W: A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br. Clin. Phamacol (1998) 46(3):245–249.
  • DRESNER M, ADAMS M, KLEIN H: Ropivacaine test dose in extradural anaesthesia. Br. J. Anaesth. (1997) 79:813.
  • ••Discusses poor suitability of ropivacaine as an iv. test dose.
  • MORTON CP, BLOOMFIELD S, MAGNUSSON A, JOZWIAK H, MCCLURE JH: Ropivacaine 0.75% for extradural anaesthesia in elective caesarean section: an open clinical and pharmacokinetic study in mother and neonate. Br. J. Anaesth. (1997) 79(1):3–8.
  • KORMAN B, RILEY RH: Convulsions induced by ropivacaine during interscalene brachial plexus block. Anesth. Analg. (1997) 85(5):1128–1129.
  • PLOWMAN AN, BOLSIN S, MATHER LE: Central nervous system toxicity attributable to epidural ropivacaine hydrochloride. Anaesth. Intensive Care (1 99 8) 26(2)204–206.
  • ABOULEISH El, ELIAS M, NELSON C: Ropivacaine-induced seizure after extradural anaesthesia. Br. J. Anaesth. (1998) 80(6):843–844.
  • RUETSCH YA, FATTINGER KE, BORGEAT A: Ropivacaine-induced convulsions and severe cardiac dysrhythmia after sciatic block. Anesthesiology (1999) 90:1784–1786.
  • EMANUELSSON BMK, ZARIC D, NYDAHL P-A, AXELSSONKH: Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers. Anesth. Analg. (1995) 81:1163–1168.
  • •Pharmacokinetics of prolonged epidural infusions.
  • LEE A, FAGAN D, LAMONT M, TUCKER GT, HALLDIN M,SCOTT DB: Disposition kinetics of ropivacaine in humans. Anesth. Analg. (1989) 69:736–738.
  • KOPACZ DJ, EMANUELSSON B-M, THOMPSON GE, CARPENTER RL, STEPHENSON, CA: Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology (1994) 81:1139–1148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.